Literature DB >> 12212929

Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts.

Marek Fischer1, Joseph K Wong, Doris Russenberger, Beda Joos, Milos Opravil, Bernhard Hirschel, Alexandra Trkola, Herbert Kuster, Rainer Weber, Huldrych F Günthard.   

Abstract

Unspliced HIV-RNA (HIV-UsRNA) associated with peripheral blood mononuclear cells (PBMCs) persists in patients on potent antiretroviral therapy even in the absence of detectable plasma HIV-RNA. To further characterize such residual HIV-RNA, cell-associated virion-encapsidated HIV and intracellular unspliced HIV-RNA were differentiated and monitored using a novel highly sensitive method. In addition, expression of HIV-mRNA encoding tat and rev was assessed. PBMCs of patients with unsuppressed plasma viraemia harboured an extracellular fraction of HIV-UsRNA, which correlated highly with intracellular HIV-RNA levels. Thus, extracellular PBMC-associated HIV-RNA may, to a significant extent, reflect nascent virions attached to productively infected cells. Upon treatment with potent antiretroviral therapy resulting in plasma viraemia <50 copies/ml, expression of cell-associated viral particles was hardly discernible in PBMCs but transcription of unspliced HIV-RNA persisted. Given the virtual absence of rev-mRNA, translation of residual HIV-UsRNA was probably precluded by retention of these transcripts in the nucleus. As shown by limiting dilution analysis, HIV-1 infected cells with such a repressed viral transcription pattern were observed at high frequencies in PBMC from untreated patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12212929

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  34 in total

1.  Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linked.

Authors:  Michael Huber; Viktor von Wyl; Christoph G Ammann; Herbert Kuster; Gabriela Stiegler; Hermann Katinger; Rainer Weber; Marek Fischer; Heribert Stoiber; Huldrych F Günthard; Alexandra Trkola
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

2.  Sulfonation pathway inhibitors block reactivation of latent HIV-1.

Authors:  Jeffrey P Murry; Joseph Godoy; Amey Mukim; Justine Swann; James W Bruce; Paul Ahlquist; Alberto Bosque; Vicente Planelles; Celsa A Spina; John A T Young
Journal:  Virology       Date:  2014-10-11       Impact factor: 3.616

3.  HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing.

Authors:  Steven A Yukl; Philipp Kaiser; Peggy Kim; Sushama Telwatte; Sunil K Joshi; Mai Vu; Harry Lampiris; Joseph K Wong
Journal:  Sci Transl Med       Date:  2018-02-28       Impact factor: 17.956

4.  RNA-mediated TILDA for improved cell capacity and enhanced detection of multiply-spliced HIV RNA.

Authors:  Hannah M Pezzi; Scott M Berry; David J Beebe; Rob Striker
Journal:  Integr Biol (Camb)       Date:  2017-11-13       Impact factor: 2.192

5.  The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence.

Authors:  Steven A Yukl; Amandeep K Shergill; Terence Ho; Maudi Killian; Valerie Girling; Lorrie Epling; Peilin Li; Lisa K Wong; Pierre Crouch; Steven G Deeks; Diane V Havlir; Kenneth McQuaid; Elizabeth Sinclair; Joseph K Wong
Journal:  J Infect Dis       Date:  2013-07-12       Impact factor: 5.226

6.  Assays for precise quantification of total (including short) and elongated HIV-1 transcripts.

Authors:  Philipp Kaiser; Sunil K Joshi; Peggy Kim; Peilin Li; Hongbing Liu; Andrew P Rice; Joseph K Wong; Steven A Yukl
Journal:  J Virol Methods       Date:  2016-12-27       Impact factor: 2.014

7.  Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection.

Authors:  Adrian Schmid; Sara Gianella; Viktor von Wyl; Karin J Metzner; Alexandra U Scherrer; Barbara Niederöst; Claudia F Althaus; Philip Rieder; Christina Grube; Beda Joos; Rainer Weber; Marek Fischer; Huldrych F Günthard
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

8.  Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA.

Authors:  Alexander O Pasternak; Karen W Adema; Margreet Bakker; Suzanne Jurriaans; Ben Berkhout; Marion Cornelissen; Vladimir V Lukashov
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

9.  Standard vaccines increase HIV-1 transcription during antiretroviral therapy.

Authors:  Christina Yek; Sara Gianella; Montserrat Plana; Pedro Castro; Konrad Scheffler; Felipe García; Marta Massanella; Davey M Smith
Journal:  AIDS       Date:  2016-09-24       Impact factor: 4.177

10.  Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome.

Authors:  Alexander O Pasternak; Suzanne Jurriaans; Margreet Bakker; Jan M Prins; Ben Berkhout; Vladimir V Lukashov
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.